Seelos Therapeutics, Inc.: cashflow_investing

Value{"amount": 0, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"}
Period2018-01-01 – 2018-09-30
Statuscurrent
EntitySeelos Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001017491-18-000103 · Open the official SEC filing →
Retrieved: 2026-08-19T09:53:13.881238+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001017491/cashflow-investing/2018-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/6bf6af8b-e2bc-40e8-86c5-88192b7a1213

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies